Increased efficacy of adipose-derived mesenchymal stem cells transduced with klotho in differentiation and maturation of oligodendrocytes in a mouse model of experimental autoimmune encephalomyelitis
Journal of Neuropathology & Experimental Neurology · 2026
DOI: 10.1093/jnen/nlaf095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuropathology & Experimental Neurology, 2026. Verfasst von Maryam Rezapour Kalkhoran und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. Hauptthemen laut MEDLINE: Encephalomyelitis, Autoimmune, Experimental, Mesenchymal Stem Cells, Cell Differentiation, Oligodendroglia. Die Arbeit nennt 70 Literaturangaben. Gefördert von: National Institute for Medical Research Development (NIMAD), Tehran, Iran, Council for Development of Regenerative Medicine and Stem Cells Technologies, Tehran, Iran, Clinical Biochemistry in the Clinical Biochemistry Department at Tarbiat Modares University.
Abstract (Originalsprache)
Current therapies for multiple sclerosis (MS) exert immunomodulatory effects but do not directly repair central nervous system (CNS) damage. Mesenchymal stem cells (MSCs) have emerged as a promising therapeutic strategy for MS, as they have been shown to promote myelin repair. Genetic modifications of MSCs have been reported to enhance their therapeutic efficiency in neurodegenerative diseases. This study aimed to investigate the therapeutic potential of MSCs engineered with secreted klotho (s-KL) in enhancing remyelination by mature oligodendrocytes in an experimental autoimmune encephalomyelitis (EAE) model in mice. The results showed that MSCs carrying s-KL alleviated clinical signs and reduced inflammation and demyelination in the CNS more significantly than MSCs. Compared to MSCs, s-KL MSCs also exhibited an enhanced capacity for differentiation and maturation of oligodendrocytes, as demonstrated by increased mRNA and protein expression of Olig2 and Nogo-A in the CNS of mice with EAE. These findings indicate that overexpression of s-KL enhances the therapeutic potential of MSCs to induce remyelination and may represent a novel approach to improve the efficacy of stem cell-based therapy in MS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Biochemistry, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
- Department of Medical Biotechnology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
ORCID-Profile: Abdolamir Allameh
Förderung
- National Institute for Medical Research Development (NIMAD), Tehran, Iran
- Council for Development of Regenerative Medicine and Stem Cells Technologies, Tehran, Iran
- Clinical Biochemistry in the Clinical Biochemistry Department at Tarbiat Modares University
- National Institute for Medical Research Development
- Council for Development of Regenerative Medicine and Stem Cells Technologies
Zitieren
APA
Rezapour Kalkhoran, M., Maleki, N., Rahbarizadeh, F., & Allameh, A. (2026). Increased efficacy of adipose-derived mesenchymal stem cells transduced with klotho in differentiation and maturation of oligodendrocytes in a mouse model of experimental autoimmune encephalomyelitis. Journal of Neuropathology & Experimental Neurology. https://doi.org/10.1093/jnen/nlaf095
Vancouver
Rezapour Kalkhoran M, Maleki N, Rahbarizadeh F, Allameh A. Increased efficacy of adipose-derived mesenchymal stem cells transduced with klotho in differentiation and maturation of oligodendrocytes in a mouse model of experimental autoimmune encephalomyelitis. Journal of Neuropathology & Experimental Neurology. 2026. doi:10.1093/jnen/nlaf095
BibTeX
@article{RezapourKalkhoran2026,
author = {Rezapour Kalkhoran, Maryam and Maleki, Narges and Rahbarizadeh, Fatemeh and Allameh, Abdolamir},
title = {Increased efficacy of adipose-derived mesenchymal stem cells transduced with klotho in differentiation and maturation of oligodendrocytes in a mouse model of experimental autoimmune encephalomyelitis},
journal = {Journal of Neuropathology & Experimental Neurology},
year = {2026},
doi = {10.1093/jnen/nlaf095}
}
EUVIMED